Christopher Pendergast - Henry Schein Senior Vice President CTO

HSIC Stock  USD 73.22  1.47  2.05%   

President

Mr. Christopher Pendergast is Senior Vice President and Chief Technology Officer of the Company. In his new role, Mr. Pendergast will be responsible for the overall leadership of the global technology function, which includes Global Information Systems, Cyber Security, and the Henry Schein Global Innovation Center. In partnership with his team, he will play a key role in shaping the Company global technology agenda and helping to accelerate and manage the introduction of innovation for Henry Schein. Mr. Pendergast will serve as a member of the Company Executive Management Committee and Technology Advisory Board, reporting toGerry Benjamin, Executive Vice President and Chief Administrative Officer of Henry Schein. Immediately prior to joiningHenry Schein, Mr. Pendergast was Chief Technology Officer for VSP Global, which provides products and services to eyecare professionals, employers, and members. Prior to VSP Global, he served in roles of increasing responsibility at Natural Organics, Inc., IdeaSphere Inc.Twinlab Corporation, and IBM Corporation since 2019.
Age 62
Tenure 6 years
Professional MarksMBA
Address 135 Duryea Road, Melville, NY, United States, 11747
Phone631 843 5500
Webhttps://www.henryschein.com
Pendergast holds both a Bachelor of Business Administration in Business Computer Information Systems, and a MBA, from Hofstra University.

Henry Schein Management Efficiency

The company has return on total asset (ROA) of 0.0388 % which means that it generated a profit of $0.0388 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0633 %, meaning that it created $0.0633 on every $100 dollars invested by stockholders. Henry Schein's management efficiency ratios could be used to measure how well Henry Schein manages its routine affairs as well as how well it operates its assets and liabilities. As of January 18, 2025, Return On Tangible Assets is expected to decline to 0.07. In addition to that, Return On Capital Employed is expected to decline to 0.10. At present, Henry Schein's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 252.4 M, whereas Other Assets are forecasted to decline to about 161.9 M.
Henry Schein currently holds 2.74 B in liabilities with Debt to Equity (D/E) ratio of 0.29, which may suggest the company is not taking enough advantage from borrowing. Henry Schein has a current ratio of 1.8, which is within standard range for the sector. Note, when we think about Henry Schein's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Jonathan LeonOwens Minor
58
Kevin PohlmanPatterson Companies
62
Kristin DietzlerPatterson Companies
N/A
Michael PintekCardinal Health
55
Lori SchechterMcKesson
58
Jeffrey JochimsOwens Minor
53
George HenriquesPatterson Companies
65
JeanFrancois BachelardEDAP TMS SA
61
Frederic PechEDAP TMS SA
56
Michael LowryOwens Minor
63
Kirk KaminskyMcKesson
N/A
Timothy RoganPatterson Companies
52
John WrightPatterson Companies
N/A
Andrew LongOwens Minor
60
Rob SchlissbergCardinal Health
N/A
Michele HolcombCardinal Health
52
Nicholas PaceOwens Minor
50
Mark ZacurOwens Minor
57
Ben BrinkerCardinal Health
N/A
Nancy FloresMcKesson
54
Donald GreggZynex Inc
N/A
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. Henry Schein operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 22000 people. Henry Schein (HSIC) is traded on NASDAQ Exchange in USA. It is located in 135 Duryea Road, Melville, NY, United States, 11747 and employs 26,000 people. Henry Schein is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Henry Schein Leadership Team

Elected by the shareholders, the Henry Schein's board of directors comprises two types of representatives: Henry Schein inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Henry. The board's role is to monitor Henry Schein's management team and ensure that shareholders' interests are well served. Henry Schein's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Henry Schein's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Ettinger, Senior Vice President - Corporate and Legal Affairs, Secretary
Walter Siegel, Senior Vice President General Counsel
Graham Stanley, VP Officer
James CPA, President
Steven Paladino, CFO, Executive VP and Executive Director
Stanley Bergman, Executive Chairman and CEO
Ronald South, Senior CFO
Stanley CPA, Executive CEO
Olga Timoshkina, Chief Finance
Lorelei McGlynn, Senior Officer
Gerard Meuchner, Chief VP
Christine Sheehy, Senior Officer
Mark Mlotek, Chief Strategic Officer, Executive VP and Director
Christopher Pendergast, Senior Vice President CTO
Bradford Connett, Chief Group
Ann Gothard, Vice Relations
James Breslawski, President, Executive Director and CEO of Global Dental Group

Henry Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Henry Schein a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Henry Schein offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Henry Schein's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Henry Schein Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Henry Schein Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Henry Schein. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For information on how to trade Henry Stock refer to our How to Trade Henry Stock guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Henry Schein. If investors know Henry will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Henry Schein listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.26)
Earnings Share
2.44
Revenue Per Share
97.561
Quarterly Revenue Growth
0.004
Return On Assets
0.0388
The market value of Henry Schein is measured differently than its book value, which is the value of Henry that is recorded on the company's balance sheet. Investors also form their own opinion of Henry Schein's value that differs from its market value or its book value, called intrinsic value, which is Henry Schein's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Henry Schein's market value can be influenced by many factors that don't directly affect Henry Schein's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Henry Schein's value and its price as these two are different measures arrived at by different means. Investors typically determine if Henry Schein is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Henry Schein's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.